[96a5a0]: / output / chiaCancer / identified / NCT01088750_identified.json

Download this file

445 lines (445 with data), 17.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
{
"info": {
"nct_id": "NCT01088750",
"official_title": "First International Inter-Group Study for Nodular Lymphocyte-Predominant Hodgkin's Lymphoma in Children and Adolescents",
"inclusion_criteria": "Healthy volunteers allowed\nMust have maximum age of 17 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "Inclusion criteria:\n\n* nodular lymphocyte-predominant Hodgkin's lymphoma confirmed by reference pathology.\n* initial stage IA/IIA (according to local staging) or relapse stage IA or IIA and residual tumour after relapse biopsy and no additional surgery planned in nLP patients relapsing after surgery alone\n* patient aged under 18 years at time of diagnosis\n* written informed consent of the patient and/or the patient's parents or guardian according to national laws\n\nExclusion criteria\n\n* pre-treatment of Hodgkin's lymphoma differing from study protocol\n* Any extra-nodal involvement\n* Inability to fulfil protocol requirements for imaging (CT, MRI, FDG-PET) at staging and response assessment\n* known hypersensitivity or contraindication to study drugs\n* prior chemotherapy or radiotherapy\n* Current or recent therapy (within 30 days prior to the start of trial treatment) with steroids\n* Current or recent (within 30 days prior to the start of trial treatment) treatment with another investigational drug or participation in another investigational trial\n* other (simultaneous) malignancies\n* severe concomitant diseases (e.g. immune deficiency syndrome)\n* known HIV positivity\n* pregnancy and / or lactation\n* females who are sexually active refusing to use effective contraception (oral contraception, intrauterine devices, barrier method of contraception in conjunction with spermicidal jelly or surgical sterile) (except for surgery only)"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have maximum age of 17 Years",
"criterions": [
{
"exact_snippets": [
"maximum age of 17 Years"
],
"criterion": "age",
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 17
}
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "* nodular lymphocyte-predominant Hodgkin's lymphoma confirmed by reference pathology.",
"criterions": [
{
"exact_snippets": [
"nodular lymphocyte-predominant Hodgkin's lymphoma"
],
"criterion": "nodular lymphocyte-predominant Hodgkin's lymphoma",
"requirement_type": "confirmation",
"expected_value": true
},
{
"exact_snippets": [
"confirmed by reference pathology"
],
"criterion": "reference pathology",
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"line": "* initial stage IA/IIA (according to local staging) or relapse stage IA or IIA and residual tumour after relapse biopsy and no additional surgery planned in nLP patients relapsing after surgery alone",
"criterions": [
{
"exact_snippets": [
"initial stage IA/IIA"
],
"criterion": "cancer stage",
"requirement_type": "initial",
"expected_value": [
"IA",
"IIA"
]
},
{
"exact_snippets": [
"relapse stage IA or IIA"
],
"criterion": "cancer stage",
"requirement_type": "relapse",
"expected_value": [
"IA",
"IIA"
]
},
{
"exact_snippets": [
"residual tumour after relapse biopsy"
],
"criterion": "residual tumour",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"no additional surgery planned"
],
"criterion": "additional surgery",
"requirement_type": "planned",
"expected_value": false
},
{
"exact_snippets": [
"nLP patients relapsing after surgery alone"
],
"criterion": "nLP patients",
"requirement_type": "relapse after surgery alone",
"expected_value": true
}
]
},
{
"line": "* patient aged under 18 years at time of diagnosis",
"criterions": [
{
"exact_snippets": [
"patient aged under 18 years"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 18
}
]
}
}
]
},
{
"line": "* written informed consent of the patient and/or the patient's parents or guardian according to national laws",
"criterions": [
{
"exact_snippets": [
"written informed consent of the patient"
],
"criterion": "informed consent",
"requirement_type": "written",
"expected_value": true
},
{
"exact_snippets": [
"patient's parents or guardian according to national laws"
],
"criterion": "informed consent",
"requirement_type": "written",
"expected_value": true
}
]
},
{
"line": "* pre-treatment of Hodgkin's lymphoma differing from study protocol",
"criterions": [
{
"exact_snippets": [
"pre-treatment of Hodgkin's lymphoma differing from study protocol"
],
"criterion": "pre-treatment of Hodgkin's lymphoma",
"requirement_type": "conformity",
"expected_value": false
}
]
},
{
"line": "* Any extra-nodal involvement",
"criterions": [
{
"exact_snippets": [
"extra-nodal involvement"
],
"criterion": "extra-nodal involvement",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Inability to fulfil protocol requirements for imaging (CT, MRI, FDG-PET) at staging and response assessment",
"criterions": [
{
"exact_snippets": [
"Inability to fulfil protocol requirements for imaging"
],
"criterion": "imaging protocol requirements",
"requirement_type": "fulfillment",
"expected_value": false
},
{
"exact_snippets": [
"CT"
],
"criterion": "CT imaging",
"requirement_type": "availability",
"expected_value": true
},
{
"exact_snippets": [
"MRI"
],
"criterion": "MRI imaging",
"requirement_type": "availability",
"expected_value": true
},
{
"exact_snippets": [
"FDG-PET"
],
"criterion": "FDG-PET imaging",
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"line": "* known hypersensitivity or contraindication to study drugs",
"criterions": [
{
"exact_snippets": [
"known hypersensitivity",
"study drugs"
],
"criterion": "hypersensitivity",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"contraindication",
"study drugs"
],
"criterion": "contraindication",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Current or recent therapy (within 30 days prior to the start of trial treatment) with steroids",
"criterions": [
{
"exact_snippets": [
"Current or recent therapy",
"with steroids"
],
"criterion": "steroid therapy",
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 30
}
]
}
}
]
},
{
"line": "* Current or recent (within 30 days prior to the start of trial treatment) treatment with another investigational drug or participation in another investigational trial",
"criterions": [
{
"exact_snippets": [
"Current or recent (within 30 days prior to the start of trial treatment) treatment with another investigational drug"
],
"criterion": "treatment with another investigational drug",
"requirement_type": "recency",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 30
}
]
}
},
{
"exact_snippets": [
"participation in another investigational trial"
],
"criterion": "participation in another investigational trial",
"requirement_type": "current",
"expected_value": true
}
]
},
{
"line": "* other (simultaneous) malignancies",
"criterions": [
{
"exact_snippets": [
"other (simultaneous) malignancies"
],
"criterion": "other malignancies",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* severe concomitant diseases (e.g. immune deficiency syndrome)",
"criterions": [
{
"exact_snippets": [
"severe concomitant diseases"
],
"criterion": "concomitant diseases",
"requirement_type": "severity",
"expected_value": "severe"
},
{
"exact_snippets": [
"immune deficiency syndrome"
],
"criterion": "immune deficiency syndrome",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* known HIV positivity",
"criterions": [
{
"exact_snippets": [
"known HIV positivity"
],
"criterion": "HIV",
"requirement_type": "positivity",
"expected_value": true
}
]
},
{
"line": "* pregnancy and / or lactation",
"criterions": [
{
"exact_snippets": [
"pregnancy"
],
"criterion": "pregnancy",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"lactation"
],
"criterion": "lactation",
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"line": "* females who are sexually active refusing to use effective contraception (oral contraception, intrauterine devices, barrier method of contraception in conjunction with spermicidal jelly or surgical sterile) (except for surgery only)",
"criterions": [
{
"exact_snippets": [
"females"
],
"criterion": "gender",
"requirement_type": "specificity",
"expected_value": "female"
},
{
"exact_snippets": [
"sexually active"
],
"criterion": "sexual activity",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"refusing to use effective contraception"
],
"criterion": "contraception use",
"requirement_type": "willingness",
"expected_value": false
},
{
"exact_snippets": [
"oral contraception",
"intrauterine devices",
"barrier method of contraception in conjunction with spermicidal jelly",
"surgical sterile"
],
"criterion": "contraception methods",
"requirement_type": "types",
"expected_value": [
"oral contraception",
"intrauterine devices",
"barrier method of contraception in conjunction with spermicidal jelly",
"surgical sterile"
]
},
{
"exact_snippets": [
"except for surgery only"
],
"criterion": "treatment type",
"requirement_type": "exclusion",
"expected_value": "surgery only"
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Inclusion criteria:",
"criterions": []
},
{
"line": "Exclusion criteria",
"criterions": []
},
{
"line": "* prior chemotherapy or radiotherapy",
"criterions": [
{
"exact_snippets": [
"prior chemotherapy"
],
"criterion": "chemotherapy",
"requirement_type": "prior treatment",
"expected_value": true
},
{
"exact_snippets": [
"prior radiotherapy"
],
"criterion": "radiotherapy",
"requirement_type": "prior treatment",
"expected_value": true
}
]
}
]
}